News About: Pharm. Industry
KFDA to approve GSK's Requip.GSK Korea announced that the KFDA approved Requip (ropinirole Hcl) tablet for the adult patient treatment with a moderate and severe primary RLS (restless leg syndrome), which i...
|
Foreign drug corporations start year-end vacation from Dec. 26.
Most of the foreign multinational drug corporations in Korea may enter their year-end holidays from Dec. 26 this year. They used to get about 15 to 20 days vacation up to the last year, but shortened it this year.
...
BMS Korea to restructure for 4 major products.
BMS Korea elected 4 major products and allocated the company resources for them as a strategy for the company sustainable growth.
The company announced on Dec. 7 that the sales department had been divided in 4 sec...
12 local companies to submit Tamiflu bulk sample to KFDA.
16 local pharmaceutical companies notified to the KFDA about their production capability of Tamiflu bulk material (oseltamivir), of which 12 companies including Hanmi actually presented the sample to the KFDA.
...
Daewoong able to produce oseltamivir and its finished product.
Daewoong submitted samples of oseltamivir bulk and its manufacturing process, covering from the starting material to the finished drug to the KFDA.
Daewoong said that they had completed to develop whole processes o...
Pharmaceutical industries to predict ongoing growth next year.
Overall pharmaceutical economy seems to continue its progress next year too on account of ever increasing trend of the aged society and therefore of a growing demand for the drugs in the treatment of chronic diseases ...
Hwail, succeeded in production of oseltamivir.
A growing number of domestic pharmaceutical companies have succeeded in the production of oseltamivir, a main ingredient of Tamiflu, an anti-bird flu drug, including Hwail pharmaceutical Inc.
Hwail announced on Nov...
CoQ10 to use for a functional food supplement.
Coenzyme Q10 seems to be approved as a functional health food supplement from next year.
Last month the KFDA made it clear that CoQ10, a prescription and non-prescription drug, would be also extended to the use of ...
Green Cross to commercialize Tamiflu with Estechpharma.
Green Cross is going to introduce Tamiflu generic product in association with Estechpharma where the main substance was succeeded in its production, oseltamivir phosphate, and the sample and data for its manufacturing...
KT&G to set 10 billion won of pharmaceutical markets.A gigantic company named KT&G announced on Dec. 5 to get a business entry into the pharmaceutical markets under the brand of functional health food supplements on KT&G Hurum (ww...
|
